Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NSTC Report On Nanotech Research Needs Is “Disappointing” – Wilson Center

This article was originally published in The Rose Sheet

Executive Summary

A prioritization of nanotechnology research needs recently released by the National Science and Technology Council is raising questions about the federal government's ability to devise an effective strategy for addressing the potential risks of materials increasingly found in consumer products on the near-atomic scale

You may also be interested in...



Still No Federal Agenda For Nanotech Safety Research; House Investigates

Delays in the release of a fully articulated federal agenda for researching the environmental health and safety implications of nanotechnology were explored at a hearing held Oct. 31 by the House Science subcommittee on Research and Science Education

Profound Beauty Grows Virtual Presence To Avoid Going Mass

"Personalized" hair-care firm Profound Beauty is growing its presence online to attract new customers while preserving its status as a prestige brand

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel